$0.009500
-0.0002-2.06%
At Close: -
$0.440500
0.434536.84%
After Hours: Aug 10, 7:59 PM EDT
15 minutes delayed
Evofem Biosciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Evofem Biosciences using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Mar 2023 | 2023-04-27 | $38.75 | $-26.25 | 247.6 % |
Dec 2022 | 2023-01-06 | $-5.00 | $-31.25 | 84.0 % |
Jun 2022 | 2022-08-04 | $-105.00 | $-120.00 | 12.5 % |
Mar 2022 | 2022-05-04 | $-360.00 | $-375.00 | 4.00 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Mar 2023 | 2023-06-16 | $5.81M | $13.50M | -57.0 % |
Mar 2023 | 2023-04-27 | $181.00K | $12.97M | -98.6 % |
Dec 2022 | 2023-01-06 | $6.37M | $9.32M | -31.6 % |
Jun 2022 | 2022-08-04 | $6.03M | $5.97M | 1.07 % |
Evofem Biosciences (EVFM) is scheduled to report earnings on November 12, 2024. The last reported earnings were for reported on August 14, 2024 for Q2.
The Actual EPS was $0.00, which hit the estimate of $0.00.
The Actual Revenue was $4.2M, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.